Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Bone Talk cover art

Bone Talk

Bone Talk

Written by: Bone Health & Osteoporosis Foundation
Listen for free

About this listen

Bone Talk is a podcast of the Bone Health & Osteoporosis Foundation that shares inspiring conversations. We examine issues around osteoporosis from diverse perspectives including patients, healthcare providers, caregivers, policy makers, researchers, advocates and innovators. Learn more about bone health, healthy active aging and strategies to protect your ability to live your best life.

2019 Bone Health & Osteoporosis Foundation (formerly the National Osteoporosis Foundation)
Hygiene & Healthy Living Political Science Politics & Government Science
Episodes
  • From Science to Patient Care: Understanding Biosimilars in Osteoporosis Treatment
    Oct 27 2026
    On this episode of Bone Talk, Ami Patel, Vice President of Science and Education at the Bone Health and Osteoporosis Foundation, welcomes Dr. Cate Lockhart, PharmD, PhD, Chief Science Officer at the Academy of Managed Care Pharmacy and Executive Director of the Biologics and Biosimilars Collective Intelligence Consortium. Together, they discuss the science behind biosimilars, the FDA approval process, and how these medications may help make osteoporosis treatment more accessible and affordable.
    Show More Show Less
    Less than 1 minute
  • From Prevention to Treatment: Advancing Men’s Bone
    Oct 6 2026
    Osteoporosis is often associated with women, but men are also at risk for bone loss and fractures as they age. On this episode of Bone Talk, host Ami Patel talks with Annette Gantz, a board-certified family nurse practitioner specializing in osteoporosis and metabolic bone disease, about why men need to pay attention to their bone health and what they can do to protect it.
    Show More Show Less
    Less than 1 minute
  • Understanding Biosimilars: A Patient's Questions Answered
    Sep 22 2026
    For people living with osteoporosis, making decisions about treatment can sometimes feel overwhelming. There are different types of medications, different ways they are given, and new treatment options continue to become available. One term patients may increasingly hear from their doctors, pharmacists, or health plans is "biosimilar." But what exactly is a biosimilar? Is it the same medication? Does it work the same way? Is it as safe? And what should a patient know if their doctor or insurance company recommends switching from a biologic medication they are already taking to a biosimilar? This episode approaches those questions from the patient perspective. Sally Fullman helps guide the conversation by asking the kinds of questions patients may have when they encounter biosimilars as part of their osteoporosis care. Answering those questions is Dr. Naga Yalla, an endocrinologist and Associate Professor of Medicine at Washington University School of Medicine.
    Show More Show Less
    Less than 1 minute
adbl_web_anon_alc_button_suppression_t1
No reviews yet